The Philadelphia Q - PCR Alert Kits are quantitative Real-Time reverse-transcription PCR assay for detection of the BCR-ABL rearrangement variants p210 or p190 (also known as t(9;22) translocation, Philadelphia chromosome). They are also used for the quantification of the ratio between BCR-ABL and ABL gene. The products are intended for use in the diagnosis and follow up of chronic myelogenous leukemia (CML), alongside patient clinical data and other laboratory test outcomes. The products follow the ELN guidelines (European Leukemia Net website: www.leukemianet.org/content/home) for the management of CML patients from diagnosis to monitoring of minimal residual disease.
Product URL : http://www.elitechgroup.com/corporate/products/med
Last Updated : 11/09/2012